A rare case of paraneoplastic cerebellar degeneration discovered by whole-body F-18 FDG PET

Clinical Nuclear Medicine

Volumn 30, Issue 10, 2005, Pages 704-706

  Rubello, D ^a,f   Vitaliani, R ^b   Rigoni, M T ^b   Rampin, L ^a   Giometto, B ^b   Casara, D ^c   Zonzin, G C ^c   Zavagno, G ^b   Capirci, C ^d   Shapiro, B ^e   Muzzio, P C ^b  

^a S MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

^b UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^c UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^d S Maria della Misericordia Rovigo Hospital   (Italy)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

Cerebellar degeneration; F18 FDG; Unknown breast cancer; Whole body PET

Indexed keywords

AUTOANTIBODY; FLUORODEOXYGLUCOSE F 18; IMMUNOGLOBULIN G; NEURONAL ANTIBODY; UNCLASSIFIED DRUG; YO ANTIBODY;

ADULT; ARTICLE; ATAXIA; BLOOD ANALYSIS; CALCIFICATION; CANCER CELL; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIPLOPIA; ECHOGRAPHY; EVOKED RESPONSE; FEMALE; GENE LINKAGE DISEQUILIBRIUM; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRADUCTAL CARCINOMA; MAMMOGRAPHY; PARANEOPLASTIC NEUROPATHY; POSITRON EMISSION TOMOGRAPHY; RARE DISEASE; SCORING SYSTEM; WHEELCHAIR; WHOLE BODY SCINTISCANNING;

ADULT; BREAST NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; PARANEOPLASTIC CEREBELLAR DEGENERATION; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RARE DISEASES; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING;

EID: 25444485446     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rlu.0000178247.44467.f5     Document Type: Article

References (8)

1. Peterson K, Rosenblum MK, Kotadines H, Posner JB. Paraneoplastic cerebellar degeneration. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurology. 1992;42:1931-1937.
2. Giometto B, Scaravilli T, Nicolao P, et al. Detection of paraneoplastic anti-neuronal antibodies on paraffin-embedded tissues. Acta Neuropathol. 1996;92:435-440.
3. Kusthoven KE, Koshy M, Paulino AC. The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor. Cancer. 2004;101:2641-2649.
4. Wong WL, Sauders M. The impact of FDG PET on the management of occult primary head and neck tumours. Clin Oncol. 2003;15:461-466.
5. Alberini JL, Belhocine T, Hustinx R, Daenen F, Rigo P. Whole-body positron emission tomography using fluorodeoxyglucose in patients with métastases of unknown primary tumours (CUP syndrome). Nucl Med Commun. 2003;24:1081-1086.
6. Delgado-Bolton RC, Fernandez-Perez C, Gonzalez-Mate A, Carreras JL. Meta-analysis of the performance of 18F-FDG PET in primary tumor detection in unknown primary tumors. J Nucl Med. 2003;44:1301-1314.
7. Wilkinson MD, Fulham MJ, Heard RN, McCaughan BC, McCarthy SW. FDG-PET in paraneoplastic neuropathy. Neurology. 2003;27:1668.
8. Stoeckli SJ, Mosna-Firlejczyk K, Goerres GW. Lymph node metastasis of squamous cell carcinoma from an unknown primary: impact of positron emission tomography. Eur J Nucl Med Mol Imaging. 2003;30:411-416.